# Interest of Pregabalin (Lyrica) on the Treatment of Reflex Earache in Head and Neck Cancer.

> **NCT02924675** · PHASE2 · TERMINATED · sponsor: **University Hospital, Lille** · enrollment: 42 (actual)

## Conditions studied

- Earache

## Interventions

- **DRUG:** Pregabalin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02924675
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-06-05
- **Primary completion:** 2018-12-12
- **Final completion:** 2018-12-12
- **Target enrollment:** 42 (ACTUAL)
- **Why stopped:** not sufficiency recruitment
- **Last updated:** 2019-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02924675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02924675, "Interest of Pregabalin (Lyrica) on the Treatment of Reflex Earache in Head and Neck Cancer.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02924675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*